Natalija Dedić Plavetić

11PUBLICATIONS
34CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Predictive and prognostic markersEnvironmental epidemiologyCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 14, 2026
Impact of Time of Administration, Fasting, and a Low-Carbohydrate Diet on Alpelisib-Associated Hyperglycemia and Efficacy: A Pilot Randomized Controlled Phase IIb Trial.

Eduard Vrdoljak, Marija Pancirov, Josipa Flam

|Feb 27, 2026
Integrative Analysis of 4-Hydroxynonenal-Modified Proteins and Plasma Metabolome in Breast Cancer Patients.

Morana Jaganjac, Matea Nikolac Perkovic, Tea Horvat

|Oct 29, 2025
A Retrospective Observational Study of Extended Adjuvant Neratinib for HER2-Positive Early-Stage Breast Cancer in a European Early Access Program.

Marija Križić, Tajana Silovski, Griet Hoste

|May 14, 2025
Treatment Sequencing in Metastatic HR+/HER2- Breast Cancer: A Delphi Consensus.

Lazar Popović, Simona Borštnar, Ivana Božović-Spasojević

|Feb 25, 2025
Precision Oncology in Clinical Practice: Two Years of Comprehensive Genomic Profiling in Croatia.

Dora Čerina Pavlinović, Jelena Šuto Pavičić, Antonela Njavro

|Jan 01, 2025
Associations between PIK3CA Mutations and Disease Free Survival in Patients with HR+, HER2- Tumors Treated with Adjuvant Hormonal Therapy: A Real-World Study in Croatia.

Dora Čerina Pavlinović, Natalija Dedić Plavetić, Ingrid Belac Lovasić

Pageof 2

Frequent Collaborators

3 joint publications

Tajana Silovski

3 joint publications

Žarko Bajić

2 joint publications

Anuska Budisavljevic

2 joint publications

Stjepko Plestina